The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats ; volume:8 ; number:1 ; day:19 ; month:6 ; year:2018 ; pages:1-13 ; date:12.2018
Scientific reports ; 8, Heft 1 (19.6.2018), 1-13, 12.2018
- Creator
- Contributor
-
Brusilovskaya, Ksenia
Supper, Paul
Bauer, David
Königshofer, Philipp
Riedl, Florian
Hayden, Hubert
Fuchs, Claudia Daniela
Stift, Judith
Oberhuber, Georg
Aschauer, Stefan
Bonderman, Diana
Gnad, Thorsten
Pfeifer, Alexander
Uschner, Frank Erhard
Trebicka, Jonel
Rohr-Udilova, Nataliya
Podesser, Bruno Karl
Peck-Radosavljevic, Markus
Trauner, Michael
Reiberger, Thomas
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-27656-y
- URN
-
urn:nbn:de:101:1-2018082200531966080372
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schwabl, Philipp
- Brusilovskaya, Ksenia
- Supper, Paul
- Bauer, David
- Königshofer, Philipp
- Riedl, Florian
- Hayden, Hubert
- Fuchs, Claudia Daniela
- Stift, Judith
- Oberhuber, Georg
- Aschauer, Stefan
- Bonderman, Diana
- Gnad, Thorsten
- Pfeifer, Alexander
- Uschner, Frank Erhard
- Trebicka, Jonel
- Rohr-Udilova, Nataliya
- Podesser, Bruno Karl
- Peck-Radosavljevic, Markus
- Trauner, Michael
- Reiberger, Thomas
- SpringerLink (Online service)
Other Objects (12)
Hämodynamische und renale Wirkung der Angiotensin-II-Typ1-Rezeptorblockade bei Ratten mit sekundärer biliärer Zirrhose
Hämodynamische und renale Wirkung der Angiotensin-II-Typ1-Rezeptorblockade bei Ratten mit sekundärer biliärer Zirrhose
The use of Albumin in liver cirrhosis - current treatment concepts and future outlook
Acute decompensation and acute-on-chronic liver failure
Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
Portal hypertension in cirrhosis : Pathophysiological mechanisms and therapy
Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment
Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with renal impairment
From molecules to patients: exploring the therapeutic role of soluble guanylate cyclase stimulators
Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies
Phosphodiesterases in the liver as potential therapeutic targets of cirrhotic portal hypertension
Effects of age and gender on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat
Hämodynamische und renale Wirkung der Angiotensin-II-Typ1-Rezeptorblockade bei Ratten mit sekundärer biliärer Zirrhose
Hämodynamische und renale Wirkung der Angiotensin-II-Typ1-Rezeptorblockade bei Ratten mit sekundärer biliärer Zirrhose
The use of Albumin in liver cirrhosis - current treatment concepts and future outlook
Acute decompensation and acute-on-chronic liver failure
Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
Portal hypertension in cirrhosis : Pathophysiological mechanisms and therapy
Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment
Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with renal impairment
From molecules to patients: exploring the therapeutic role of soluble guanylate cyclase stimulators
Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies
Phosphodiesterases in the liver as potential therapeutic targets of cirrhotic portal hypertension
Effects of age and gender on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat
Hämodynamische und renale Wirkung der Angiotensin-II-Typ1-Rezeptorblockade bei Ratten mit sekundärer biliärer Zirrhose
Hämodynamische und renale Wirkung der Angiotensin-II-Typ1-Rezeptorblockade bei Ratten mit sekundärer biliärer Zirrhose
The use of Albumin in liver cirrhosis - current treatment concepts and future outlook
Acute decompensation and acute-on-chronic liver failure
Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
Portal hypertension in cirrhosis : Pathophysiological mechanisms and therapy
Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment
Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with renal impairment
From molecules to patients: exploring the therapeutic role of soluble guanylate cyclase stimulators
Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies
Phosphodiesterases in the liver as potential therapeutic targets of cirrhotic portal hypertension